IQVIA™ Real-World Insights Bibliography

Comparison of Laboratory and On-Field Performance of American Football Helmets
Author(s): Ann M Bailey 1, Timothy L McMurry 2, Joseph M Cormier 3, James R Funk 3, Jeff R Crandall 3, Christina D Mack 4, Barry S Myers 5, Kristy B Arbogast 6
Affiliations(s): 1 Biomechanics Consulting and Research, LLC, Charlottesville, VA, USA. abailey@bicorellc.com. 2 Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA. 3 Biomechanics Consulting and Research, LLC, Charlottesville, VA, USA. 4 IQVIA, Durham, NC, USA. 5 Department of Biomedical Engineering, Duke University, Durham, NC, USA. 6 Center for Injury Research and Prevention, Children's Hospital of Philadelphia, Pennsylvania, USA.
Publication(s):  PMID: 33025320 DOI: 10.1007/s10439-020-02627-5
Document Type(s): 
Countries: USA,
Click here for the abstract
C:
Y:
Injuries,
2020
  L:
A:
English
Clinical setting: Primary care, direct to patient research, Machine Learning/Artificial Intelligence, Observational study, Public Health,
  Add to report
 
 
Sports Performance and Injury Research: Methodologic Limitations and Recommendations for Future Improvements
Author(s): Travis G.MaakM.D.ab Christina D.MackPh.D., MSPHacBrian J.ColeMD, M.B.A.adMackenzie M.HerzogPh.D, M.P.HacJohnDifioriM.D., F.A.M.S.S.M.aPeterMeiselM.S.P.H.a
Affiliations(s): a National Basketball Association, Research Committee, U.S.A. b Department of Orthopaedics, University of Utah, Salt Lake City, Utah, U.S.A. c IQVIA Real-World Solutions, Research Triangle Park, Durham, North Carolina, U.S.A. d Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, Illinois, U.S.A.
Publication(s):  https://doi.org/10.1016/j.arthro.2020.08.038
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Injuries,
2020
  L:
A:
English
Clinical setting: Primary care, Cost of illness, direct-to-patient research, Machine Learning/Artificial Intelligence, Market impact, Methodology,
  Add to report
 
 
Incidence of Lower Extremity Injury in the National Football League: 2015 to 2018
Author(s): Christina D. Mack, PhD, MSPH*, †, Richard W. Kent, PhD‡, Michael J. Coughlin, MD§, ‖, Kristin Y. Shiue, MPH†, Leigh J. Weiss, PT, DPT, ATC¶, James R. Jastifer, MD#, **, Edward M. Wojtys, MD††, Robert B. Anderson, MD‡‡on behalf of the NFL Musculoskeletal Committee
Affiliations(s): †IQVIA Real World Solutions, Research Triangle Park, North Carolina, USA ‡Center for Applied Biomechanics, University of Virginia, Biomechanics Consulting & Research (Biocore), Charlottesville, Virginia, USA §University of California, San Francisco, San Francisco, California, USA ‖Coughlin Foot and Ankle Clinic, Saint Alphonsus Hospital, Boise, Idaho, USA ¶New York Football Giants, Quest Diagnostics Training Center, East Rutherford, New Jersey, USA #Borgess Orthopedics, Kalamazoo, Michigan, USA **WMU Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, USA ††MedSport, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan, USA ‡‡Bellin Health Titletown Sports Medicine and Orthopedics, Green Bay, Wisconsin, USA
Publication(s):  https://doi.org/10.1177/0363546520922547
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Injuries,
2020
  L:
A:
English
Epidemiological study,
  Add to report
 
 
Clinical Research in the National Football League: The Player Scientific and Medical Research Protocol
Author(s): Christina Mack 1, Matthew Matava 2, Kristina Zeidler 1, Allen Sills, Gary Solomon
Affiliations(s): 1IQVIA Research Triangle Park, NC. 2Department of Orthopedic Surgery, Washington University School of Medicine St. Louis, MO.
Publication(s):  PMID: 32358299 DOI: 10.1249/JSR.0000000000000711
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Injuries,
2020
  L:
A:
English
Epidemiological study,
  Add to report
 
 
RWE is the Future of Clinical Research: Time to Get Onboard
Author(s): Nancy A. Dreyer,
Affiliations(s): Chief Scientific Officer and Senior VP, IQVIA Real World Solutions
Publication(s):  PharmaVOICE - March 2020
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Health economics, Health status & patient reported outcomes,
2020
  L:
A:
English
Economic evaluation, Literature Review, Market impact,
  Add to report
 
 
Comparison of electronic self-reported prescription medication use during pregnancy with the national prescription register in Denmark
Author(s): Maja Laursen 1, Christine E Hallgreen 2 3, Nancy Dreyer 4, Alison Bourke 5, Shahrul Mt-Isa 2 6, Stella Blackburn 5
Affiliations(s): 1The Danish Health Data Authority, Copenhagen, Denmark. 2School of Public Health, Imperial College London, London, UK. 3Copenhagen Center for Regulatory Science, Department of Pharmacy, SUND, University of Copenhagen, Copenhagen, Denmark. 4IQVIA Real-World and Analytic Solutions, Boston, Massachusetts. 5IQVIA Real-World and Analytic Solutions, London, UK. 6Biostatistics and Research Decision Sciences, MSD Research Laboratories, London, UK.
Publication(s):  Pharmacoepidemiol Drug Saf . 2020 Mar;29(3):328-336. doi: 10.1002/pds.4937. Epub 2019 Dec 6.
Document Type(s): Article,
Countries: Denmark, UK, USA,
Click here for the abstract
C:
Y:
Patient Registries & Real-World Study Methods, Pregnancy,
2020
  L:
A:
English
Epidemiological study, Methodology, Patient questionnaire, Real World Data,
  Add to report
 
 
Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms
Author(s): Mehmet Burcu 1, Nancy A Dreyer 2, Jessica M Franklin 3, Michael D Blum 4, Cathy W Critchlow 5, Eleanor M Perfetto 6, Wei Zhou 1
Affiliations(s): 1Center for Observational and Real-World Evidence, Merck & Co., Inc., West Point, Pennsylvania, United States. 2Real-World Solutions, IQVIA, Cambridge, Massachusetts. 3Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 4Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, U.S. Food and Drug Administration, White Oak, Maryland. 5Center for Observational Research, Amgen Inc., Thousand Oaks, California. 6National Health Council, Washington, District of Columbia, and University of Maryland Baltimore (UMB), Baltimore, Maryland.
Publication(s):  Pharmacoepidemiol Drug Saf . 2020 Oct;29(10):1228-1235. doi: 10.1002/pds.4975. Epub 2020 Mar 11.
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Drug safety,
2020
  L:
A:
English
Epidemiological study, Real World Data, Real World Evidence,
  Add to report
 
 
Considerations when evaluating real-world data quality in the context of fitness for purpose
Author(s): Matthew W Reynolds 1, Alison Bourke 2, Nancy A Dreyer 3
Affiliations(s): 1Real World Solutions, IQVIA, Maryland, USA. 2Real World Solutions, IQVIA United Kingdom, UK. 3Real World Solutions, IQVIA, Massachusetts, USA.
Publication(s):  Pharmacoepidemiol Drug Saf . 2020 Oct;29(10):1316-1318. doi: 10.1002/pds.5010. Epub 2020 May 6.
Document Type(s): Article,
Countries: UK, USA,
Click here for the abstract
C:
Y:
Health status & patient reported outcomes,
2020
  L:
A:
English
Real World Data, Real World Evidence,
  Add to report
 
 
Leveraging Real-World Data for COVID-19 Research: Challenges and Opportunities
Author(s): Matthew W. Reynolds, Jennifer B Christian, Christina D Mack, Marni Hall and Nancy A Dreyer
Affiliations(s): Matthew W. Reynolds, PhD, FISPE Vice President, Real World Evidence, IQVIA Christina Mack, PhD, MSPH Vice President, Epidemiology and Clinical Evidence, IQVIA Adjunct Faculty, UNC-Chapel Hill Marni Hall, PhD, MPH Vice President of Clinical Evidence, IQVIA Nancy Dreyer, PhD, FISPE Chief Scientific O?cer and Senior Vice President, IQVIA Jennifer B. Christian, PharmD, MPH, PhD, FISPE
Publication(s):  Precision Medicine 2020; 6 (2), June
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
COVID-19,
2020
  L:
A:
English
Data linkage, Observational study, Population Based Study, Real World Data, Real World Evidence,
  Add to report
 
 
Bridging the Gap Between RCTs and RWE Through Endpoint Selection
Author(s): Robert J LoCasale 1, Chris L Pashos 2, Ben Gutierrez 3, Nancy A Dreyer 4, Toby Collins 5, Alan Calleja 5, Michael J Seewald 6, Jonathan M Plumb 7, Johan Liwing 8, Maurille Feudjo Tepie 9, Sajan Khosla 10
Affiliations(s): 1Real World Evidence, Sanofi, Bridgewater, NJ, USA. 2AbbVie, Chicago, IL, USA. 3GSK, Philadelphia, PA, USA. 4IQVIA, Real-World Solutions, Cambridge, MA, USA. 5IQVIA, Real-World Solutions, London, UK. 6Novartis Pharma AG/Pharma Medical Affairs, Basel, Switzerland. 7Ferring Pharmaceuticals SA, St Prex, Switzerland. 8CellProtect Nordic Pharmaceuticals, Stockholm, Sweden. 9Center for Observational Research, Amgen, Cambridge, UK. 10Real-World Evidence Center of Excellence, AstraZeneca, Cambridge, UK. sajan.khosla@astrazeneca.com.
Publication(s):  Published online 2020 Jul 6. doi: 10.1007/s43441-020-00193-5
Document Type(s): Article,
Countries: Sweden, Switzerland, UK, USA,
Click here for the abstract
C:
Y:
Health status & patient reported outcomes,
2020
  L:
A:
English
Real World Data, Real World Evidence,
  Add to report
 
 
First Page Previous Page  2 of 66 Next Page Last Page